Forma Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2008)

Organization Overview

First Clinical Trial
2015
NCT02543879
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Forma Therapeutics | Forma Therapeutics, Inc.